Safety and Efficacy in Randomized Controlled Trials of Second-Generation Antipsychotics Versus Placebo for Cognitive Impairments in Schizophrenia: A Meta-Analysis

J Clin Psychopharmacol. 2022 Mar-Apr;42(2):227-229. doi: 10.1097/JCP.0000000000001232.
No abstract available

Publication types

  • Meta-Analysis

MeSH terms

  • Antipsychotic Agents*
  • Cognitive Dysfunction* / drug therapy
  • Cognitive Dysfunction* / etiology
  • Humans
  • Randomized Controlled Trials as Topic
  • Schizophrenia* / drug therapy

Substances

  • Antipsychotic Agents